Analysis of the health economics portfolio funded by the National Institutes of Health in response to published guidance by Burgdorf, Caitlin E, Riley, William T, Akbar, Farheen, Zuehlke, Abbey D, Bibb, Katrina, Eshleman, Heather D, Shah, Ami, Belis, Deshiree, Spittel, Michael, Fearon, Paula

Get full text

Shigella Effector OspB Activates mTORC1 in a Manner That Depends on IQGAP1 and Promotes Cell Proliferation by Lu, Richard, Herrera, Bobby Brooke, Eshleman, Heather D, Fu, Yang, Bloom, Alexander, Li, Zhigang, Sacks, David B, Goldberg, Marcia B

Get full text

The Shigella Spp. Type III Effector Protein OspB Is a Cysteine Protease by Wood, Thomas E, Westervelt, Kathleen A, Yoon, Jessica M, Eshleman, Heather D, Levy, Roie, Burnes, Henry, Slade, Daniel J, Lesser, Cammie F, Goldberg, Marcia B

Get full text

Protein targeting and degradation are coupled for elimination of mislocalized proteins by Hessa, Tara, Sharma, Ajay, Mariappan, Malaiyalam, Eshleman, Heather D., Gutierrez, Erik, Hegde, Ramanujan S.

Get full text

Distinct Requirements of Adenovirus E1b55K Protein for Degradation of Cellular Substrates by Schwartz, Rachel A, Lakdawala, Seema S, Eshleman, Heather D, Russell, Matthew R, Carson, Christian T, Weitzman, Matthew D

Get full text

Shigella Effector OspB Activates mTORC1 in a Manner That Depends on IQGAP1 and Promotes Cell Proliferation: e1005200 by Lu, Richard, Herrera, Bobby Brooke, Eshleman, Heather D, Fu, Yang, Bloom, Alexander, Li, Zhigang, Sacks, David B, Goldberg, Marcia B

Get full text

Distinct Requirements of Adenovirus Elb55K Protein for Degradation of Cellular Substrates by SCHWARTZ, Rachel A, LAKDAWALA, Seema S, ESHLEMAN, Heather D, RUSSELL, Matthew R, CARSON, Christian T, WEITZMAN, Matthew D

Get full text

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial by Grinsztejn, Beatriz, MD, Hosseinipour, Mina C, MD, Ribaudo, Heather J, PhD, Swindells, Susan, MBBS, Eron, Joseph, MD, Chen, Ying Q, PhD, Wang, Lei, PhD, Ou, San-San, MS, Anderson, Maija, MN, McCauley, Marybeth, MPH, Gamble, Theresa, PhD, Kumarasamy, Nagalingeshwaran, MB, Hakim, James G, MD, Kumwenda, Johnstone, FRCP, Pilotto, Jose H S, MD, Godbole, Sheela V, MD, Chariyalertsak, Suwat, MD, de Melo, Marineide Gonçalves, MD, Mayer, Kenneth H, MD, Eshleman, Susan H, MD, Piwowar-Manning, Estelle, MT, Makhema, Joseph, FRCP, Mills, Lisa A, MD, Panchia, Ravindre, MBBCh, Sanne, Ian, MBBCh, Gallant, Joel, MD, Hoffman, Irving, PA, Taha, Taha E, MBBS, Nielsen-Saines, Karin, MD, Celentano, David, ScD, Essex, Max, DVM, Havlir, Diane, MD, Cohen, Myron S, Dr

Get full text

A Randomized Trial of 2 Different 4-Drug Antiretroviral Regimens versus a 3-Drug Regimen, in Advanced Human Immunodeficiency Virus Disease by Fischl, Margaret A., Ribaudo, Heather J., Collier, Ann C., Erice, Alejo, Giuliano, Marina, Dehlinger, Marjorie, Eron, Joseph J., Saag, Michael S., Hammer, Scott M., Vella, Stefano, Morse, Gene D.

Get full text